跳至主要内容
临床试验/CTRI/2024/10/075001
CTRI/2024/10/075001尚未招募2 期

A Clinical Study to evaluate the safety and efficacy of Unani Formulations in Childhood Psoriasis

Department of Amraze Jild Wa Zohrawiya1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年10月15日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Improvement in PASI SCORE, PGA SCORE, BSA involved

研究概览

简要总结

To provide the safe and cost effective treatment of childhood psoriasis.

Null hypothesis: There is no significant effect of the trial formulations on the patients before and after the study

Alternate hypothesis: There is significant effect of the trial formulations on the patients before and after the study.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
0.00 Year(s) 至 15.00 Year(s)(—)
性别
All

入选标准

  • PASI (Psoriasis Area and Severity Index) score more than 10
  • PGA (Physicians Global Assessment) score: 3–
  • BSA is more than 10%.
  • A clinically stable patient.
  • Patients up to 15 years of age.
  • Patients of either sex.
  • Patients are not on any concomitant therapy.
  • Patients who have left the treatment at least 2 months ago.
  • The patient or guardian agreed and signed the written consent proforma.

排除标准

  • Doubtful cases of childhood psoriasis.
  • Childhood psoriasis with secondary infection.
  • Immunocompromised patients.
  • Patients above the age of 15 years.

结局指标

主要结局

Improvement in PASI SCORE, PGA SCORE, BSA involved

时间窗: Monthly assessment for 6 months +2 months follow up.

次要结局

  • Improvement in itching erythema induration(Monthly assessment for 6 months plus two months follow up)

研究者

发起方
Department of Amraze Jild Wa Zohrawiya
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Hafsa Tariq

Ajmal Khan Tibbiya College

研究点 (1)

Loading locations...

相似试验

A Clinical Study to find out safety and efficacy of... | 临床试验